Basic characteristics of research. by Xiaodong Jia (783460)

“…Subgroup analysis based on treatment duration showed heterogeneity and a potential decrease in total cholesterol levels after 12 months of treatment (MD = -0.03, 95% CI [-0.21, -0.15], <i>P</i> = 0.76). …”

Analyses of neutralization and binding by 3BNC117. by Rajesh P. Ringe (3118764)

miR-204-5p inhibits glioma cell growth <i>in vitro</i>. by Zhiqiang Xia (764303)

“…<p>A, More than 200-fold increase in the expression of miR-204-5p was observed in Lv-miR-204-5p-LN229 cells and Lv-miR-204-5p-U87 cells compared to the LEV group by qRT-PCR. …”

IMM correlates with hind limb muscle weight in SOD1^G93A mice as disease progresses. by Laura Pasetto (4906006)

“…(B-C) A correlation analysis was done with the mean values of the IMM and of the muscle weight of TA (B) and Gastrocnemius (GC) (C) for the different experimental groups. …”

Image_2_Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma.tiff by Meng-Ke Liu (10306315)

“…<p>Lymphoma cells expressing CD5 (CD5+) confer inferior outcome of diffuse large B-cell lymphoma (DLBCL), especially in non–MYC/BCL2 double expressor (non-DE) patients. …”

Image_1_Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma.tiff by Meng-Ke Liu (10306315)

“…<p>Lymphoma cells expressing CD5 (CD5+) confer inferior outcome of diffuse large B-cell lymphoma (DLBCL), especially in non–MYC/BCL2 double expressor (non-DE) patients. …”

Characteristics of included studies. by Rong Pi (21743379)

“…The meta-analysis was conducted using Stata 18.0 software, employing a random-effects model to pool the mean score and standard deviation of the Occupational Fatigue Exhaustion Recovery (OFER) scale. …”

Circular statistics results. by David A. Donoso (3315816)

Sensitivity analysis for acute fatigue subscale. by Rong Pi (21743379)

“…The meta-analysis was conducted using Stata 18.0 software, employing a random-effects model to pool the mean score and standard deviation of the Occupational Fatigue Exhaustion Recovery (OFER) scale. …”

Factors related to nurses’ occupational fatigue. by Rong Pi (21743379)

“…The meta-analysis was conducted using Stata 18.0 software, employing a random-effects model to pool the mean score and standard deviation of the Occupational Fatigue Exhaustion Recovery (OFER) scale. …”

Sensitivity analysis for inter-shift subscale. by Rong Pi (21743379)

“…The meta-analysis was conducted using Stata 18.0 software, employing a random-effects model to pool the mean score and standard deviation of the Occupational Fatigue Exhaustion Recovery (OFER) scale. …”

Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc by Maria Totaro (11665708)

“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I²= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I² = 0%, P=0.97). …”

BafA1 attenuates PtdIns3P elevation but does not ameliorate PtdIns(3,5)P₂ reduced by YM201636. by Diego Sbrissa (2653723)

“…YM201636 decreased PtdIns5P and PtdIns(3,5)P₂ and both remained similarly reduced by pretreatment with BafA1. …”